⌘K

Login Start Free

Home/Filings/4/0001127602-24-002746

4//SEC Filing

Nicholson Nur 4

Accession 0001127602-24-002746

CIK 0001492422other

View on SEC.gov Company Profile

Filed

Jan 30, 7:00 PM ET

Accepted

Jan 31, 4:31 PM ET

Size

4.5 KB

Accession

0001127602-24-002746

Insider Transaction Report

Form 4

Period: 2024-01-29

Apellis Pharmaceuticals, Inc.APLS

Chief Technical Officer

Transactions

Sale
Common Stock
2024-01-29$64.14/sh−835$53,555→ 67,507 total

Footnotes (1)

[F1]This represents shares sold to cover tax withholding on the Restricted Stock Units released on 01/26/2024.

Documents

1 file

4
form4.xmlPrimary
PRIMARY DOCUMENT

Issuer

Apellis Pharmaceuticals, Inc.

CIK 0001492422

Entity typeother

Related Parties

1

filerCIK 0001827317

Filing Metadata

Form type: 4
Filed: Jan 30, 7:00 PM ET
Accepted: Jan 31, 4:31 PM ET
Size: 4.5 KB

View on SEC.gov